Celldex Therapeutics, Inc. (CLDX): Shares Outstanding
Figures left out. The filed Shares Outstanding for the years ended 2019-12-31, 2020-12-31, 2021-12-31, 2022-12-31 are not shown: shares outstanding out of scale with weighted shares. That usually means the filing tagged the figure in the wrong unit.
66.55M
As of 2025-12-31
78.50M
As of 2026-06-30
-3.9%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 66.55M | +0.3% | 2026-02-25, Balance as of period end |
| 2024-12-31 | 66.37M | +18.8% | 2026-02-25, Balance as of period end |
| 2023-12-31 | 55.88M | n/a | 2025-02-27, Balance as of period end |
| No annual figure between 2018-12-31 and 2023-12-31. | |||
| 2018-12-31 | 11.96M | +29.5% | 2020-03-26, Balance as of period end |
| 2017-12-31 | 9.23M | -92.3% | 2019-03-07, Balance as of period end |
| 2016-12-31 | 120.52M | +22.1% | 2018-03-07, Balance as of period end |
| 2015-12-31 | 98.69M | +10.1% | 2017-03-14, Balance as of period end |
| 2014-12-31 | 89.59M | +0.4% | 2016-02-25, Balance as of period end |
| 2013-12-31 | 89.25M | +38.7% | 2015-02-24, Balance as of period end |
| 2012-12-31 | 64.36M | n/c | 2014-03-03, Balance as of period end |
| 2011-12-31 | 44.21M | +37.9% | 2013-03-08, Balance as of period end |
| 2010-12-31 | 32.06M | n/a | 2012-03-08, Balance as of period end |